Tela Bio (NASDAQ: TELA) — Perfil da empresa, notícias e dados financeiros
Tela Bio develops biologically enhanced soft tissue repair solutions for hernia and reconstructive surgery.
Tela Bio
Tela Bio (NASDAQ:TELA) is a company that specializes in developing and marketing a broad range of innovative, cost-effective, and biologically enhanced soft tissue repair solutions designed to address the needs of patients, surgeons, and healthcare systems worldwide. Its portfolio mainly focuses on the reinforcement of soft tissue repairs in hernia repair, abdominal wall reconstruction, and plastic and reconstructive surgery. Utilizing its proprietary "OviTex" technology, Tela Bio aims to advance the clinical outcomes in soft tissue repair while reducing overall healthcare costs. The company's commitment is towards improving patient care and outcomes through the integration of biologic and synthetic materials. Tela Bio is dedicated to innovation, excellence, and the ongoing development of technologies that meet the evolving demands of the surgical community.
Resumo
Operações
Produtos e/ou serviços de Tela Bio
- OviTex Reinforced BioScaffolds (RBSs) for hernia repair and abdominal wall reconstructions, combining polymer and biologic materials.
- OviTex PRS Reinforced BioScaffolds specifically designed for plastic and reconstructive surgery, offering tailored absorption and mechanical strength.
- OviTex LPR Reinforced BioScaffolds for laparoscopic and robotic surgeries, featuring lighter designs for minimally invasive procedures.
- Professional Education and Training Programs, providing healthcare professionals with knowledge and skills on the latest advancements in surgical techniques and applications of their products.
equipe executiva do Tela Bio
- Jeffrey BlizardPresident
- Heather C. GetzCEO, Principal Financial Officer & Director
- Megan SmeykalVP, Corporate Controller, Chief Accounting Officer & Principal Accounting Officer
- Paul TalmoChief Technology Officer
- D. Taylor OcasioGeneral Counsel & Corporate Secretary
- Jim HagenSenior VP of Strategic Commercial Operations & Marketing
- Jennifer Lou ArmstrongSenior Vice President of Human Resources
- Gregory A. FirestoneChief Business Officer
- Michael LeonardSenior Vice President of Technical Operations
- Howard N. LangsteinChief Medical Officer
Principais indicadores financeiros
Resultados divulgados pela Tela Bio, em USD.
- Cap. de mercado
- 43,3 mi
- Receita (TTM)
- 79,9 mi
- P/L
- —
- LPA (diluído, TTM)
- -0.7
- Dividend yield
- —
- Margem de lucro
- -51.5%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 80,3 mi | -33,8 mi | -38,8 mi | |
| 69,3 mi | -34,1 mi | -37,8 mi | |
| 58,5 mi | -44,1 mi | -46,7 mi | |
| 41,4 mi | -39 mi | -44,3 mi |